• Mashup Score: 0

    Hidradenitis suppurativa (HS) is a chronic, dermatologic illness increasingly recognized in the pediatric population. For adolescents with HS, pain and scars can result in long-lasting psychosocial distress and functional impairment. Existing data on HS demonstrate that prevalence varies widely by race/ethnicity but there is no clear explanation as to why.1 In particular, studies of pediatric…

    Tweet Tweets with this article
    • To estimate the prevalence of adolescent population with #hidradenitissuppurativa at the neighborhood level in San Diego County, authors performed an institutional review board-approved retrospective chart review of patients ages 15-19 diagnosed with HS. https://t.co/mNnEfcfbiV

  • Mashup Score: 0

    To the Editor: On March 11, 2020, the World Health Organization elevated the coronavirus disease 2019 (COVID-19) to global pandemic status. Systems-level changes in governance, health care resource allocation, and social-behavioral norms developed worldwide in efforts to reduce viral spread. An unintended consequence of these changes was a disruption of routine preventative health care practice,…

    Tweet Tweets with this article
    • To evaluate the longitudinal effects of care interruptions during the COVID-19 pandemic on #melanoma diagnoses, the authors performed a retrospective cohort analysis of patients evaluated in a tertiary care setting. Learn more in JAAD International. https://t.co/dzzQXkxT62

  • Mashup Score: 0

    To the Editor: Vitiligo is an acquired depigmenting skin disorder due to the absence of functional melanocytes affecting up to 1% of the general population.1 Initial treatment typically involves topical corticosteroids, topical calcineurin inhibitors, and phototherapy; however, topical Janus kinase inhibitors (JAKi) are being explored as a potential treatment option. This systematic review…

    Tweet Tweets with this article
    • This systematic review in JAAD International examines the efficacy and safety of topical Janus kinase inhibitors (JAKi) therapies in #vitiligo. https://t.co/FZVsamXBOO

  • Mashup Score: 0

    To the Editor: Bullous pemphigoid (BP) is an autoimmune disorder characterized by tense blisters and intense pruritus.1 Initial treatment typically involves the use of topical and systemic corticosteroids, with refractory cases often requiring systemic immunosuppressives or biologics. This systematic review examines treatment outcomes of systemic biologics for BP refractory to other systemic…

    Tweet Tweets with this article
    • This systematic review examines treatment outcomes of systemic biologics for bullous pemphigoid refractory to other systemic therapies. https://t.co/uX2ffiVeQd